JPMorgan Chase & Co. strategists forecast a rise in the Cboe Volatility Index (VIX) in 2024, marking a climb from its lowest point since pre-pandemic levels experienced this year. The extent of this increase, they suggest, hinges upon the economic vigour during the year ahead. VIX Projections and Economic FactorsRead More →
The holdings of foreign portfolio investors’ (FPI) in Indian stocks have reached their lowest levels in a decade amid extensive selling of domestic equities by overseas investors since September 2023. The aggregate holdings of FPIs stand at ₹54.5 lakh crore, implying 16.6% holdings of overall Indian equities as of NovemberRead More →
After an over 43 percent jump in the stock in 2023 YTD, brokerage house Elara Securities reiterated its ‘sell’ call on RITES with a target price of ₹370, indicating a downside of over 21 percent. The stock has gained 23.5 percent in the last 1 year. It hit its recordRead More →
Sensex Today | Share Market Live Updates: Indian benchmark indices closed in the green on Tuesday, with the Sensex at 65,930 at the Nifty just under 19,800. As many as four IPOs will open for subscription today – Tata Technologies, Gandhar Oil Refinery, Flair Writing Industries and Fedbank Financial Services.Read More →
The combined market valuation of four leading firms in the top-10 list decreased by ₹23,417.15 crore last week, with Infosys and Tata Consultancy Services (TCS) facing significant declines, PTI reported. IT major Infosys recorded the most substantial drop, with its market capitalisation falling by ₹8,465.09 crore to ₹5,68,064.77 crore. While,Read More →
Sensex Today | Share Market Updates: FIIs extended their selling spree on Tuesday, November 7, as domestic markets snapped their three-day winning run on profit booking amid weak global cues. The DIIs infused ₹700.28 crore in Indian stocks today. Oil prices fell as worries continue about how much fuel theRead More →
Sensex Today | Share Market Updates: FIIs on Monday sold stocks of Indian companies resulting in a net outflow of ₹549.37 crore, according to NSE data. DIIs bought equities resulting in an inflow of ₹595.70 crore, the exchange data showed. Oil held a modest advance after Saudi Arabia and Russia’sRead More →
Pharma major Sun Pharma posted a 5 percent year-on-year (YoY) rise in its consolidated net profit to ₹2,375.5 crore for the July-September quarter versus ₹2,262.22 crore in the same period last year. Meanwhile, its revenue rose over 11 percent YoY to ₹12,192 crore in the quarter under review as againstRead More →
Mumbai: Stocks staged a rebound on Friday following a six-day decline that eroded ₹17.95 trillion in investor wealth. Analysts, however, refrained from calling this a recovery, labelling it as a “dead cat bounce” whose life is uncertain, given escalating geopolitical tensions and rising bond yields in the US. The riseRead More →
MUMBAI : Indian stocks extended their decline for a fifth straight session on sustained selling by foreign and retail direct investors amid rising bond yields in the US, the Israel-Hamas war, which is now threatening to engulf other countries, and rising crude prices. Market experts expect stocks to fall further.Read More →
